手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| SCORAD指数（アトピー性皮膚炎スコアリング）× | POEM（患者中心型湿疹重症度評価尺度）× | |
|---|---|---|
| 分野 | 皮膚科学 | 皮膚科学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1993 | 2004 |
| 提唱者≠ | European Task Force on Atopic Dermatitis (ETFAD) | Charman CR, Venn AJ, Williams HC |
| 種類≠ | Clinician-rated | Self-report |
| 原典≠ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ | Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol. 2004;140(12):1513-1519. DOI ↗ |
| 別名 | SCORAD Index | POEM Score |
| 関連≠ | 3 | 2 |
| 概要≠ | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. | The POEM is a brief, patient-administered severity measure for atopic dermatitis that focuses on frequency of symptoms experienced over the past week. Developed by Charman, Venn, and Williams in 2004, it emphasizes the patient's lived experience rather than clinician observation, making it practical for routine clinical practice and remote monitoring. POEM is increasingly used alongside objective measures in clinical trials and outpatient care. |
| ScholarGateデータセット ↗ |
|
|